Cargando…

Comparative study of Revogene GBS LB assay and GeneXpert GBS LB assay for the detection of group B Streptococcus in prenatal screening samples

BACKGROUND: Group B Streptococcal (GBS) infections in the United States are a leading cause of meningitis and sepsis in newborns. The CDC therefore recommends GBS screening for all pregnant women at 35–37 weeks of gestation and administration of intrapartum prophylaxis (in those that tested positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Choera, Tsokyi, Jung-Hynes, Brittney, Chen, Derrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958782/
https://www.ncbi.nlm.nih.gov/pubmed/31937247
http://dx.doi.org/10.1186/s12879-019-4756-y